Neural Tube Closure in Mouse Whole Embryo Culture

Genetic mouse models are an important tool in the study of mammalian neural tube closure (Gray & Ross, 2009; Ross, 2010). However, the study of mouse embryos in utero is limited by our inability to directly pharmacologically manipulate the embryos in isolation from the effects of maternal metabolism on the reagent of interest. Whether using a small molecule, recombinant protein, or siRNA, delivery of these substances to the mother, through the diet or by injection will subject these unstable compounds to a variety of bodily defenses that could prevent them from reaching the embryo. Investigations in cultures of whole embryos can be used to separate maternal from intrinsic fetal effects on development.Here, we present a method for culturing mouse embryos using highly enriched media in a roller incubator apparatus that allows for normal neural tube closure after dissection (Crockett, 1990). Once in culture, embryos can be manipulated using conventional in vitro techniques that would not otherwise be possible if the embryos were still in utero. Embryo siblings can be collected at various time points to study different aspects of neurulation, occurring from E7-7.5 (neural plate formation, just prior to the initiation of neurulation) to E9.5-10 (at the conclusion of cranial fold and caudal neuropore closure, Kaufman, 1992). In this protocol, we demonstrate our method for dissecting embryos at timepoints that are optimal for the study of cranial neurulation. Embryos will be dissected at E8.5 (approx. 10-12 somities), after the initiation of neural tube closure but prior to embryo turning and cranial neural fold closure, and maintained in culture till E10 (26-28 somities), when cranial neurulation should be complete.     

Time dependence of recruitment and derecruitment in the lung: a theoretical model.

Recruitment and derecruitment (R/D) of air spaces within the lung is greatly enhanced in lung injury and is thought to be responsible for exacerbating injury during mechanical ventilation. There is evidence to suggest that R/D is a time-dependent phenomenon. We have developed a computer model of the lung consisting of a parallel arrangement of airways and alveolar units. Each airway has a critical pressure (Pcrit) above which it tends to open and below which it tends to close but at a rate determined by how far pressure is from Pcrit. With an appropriate distribution of Pcrit and R/D velocity characteristics, the model able to produce realistic first and second pressure-volume curves of a lung inflated from an initially degassed state. The model also predicts that lung elastance will increase transiently after a deep inflation to a degree that increases as lung volume decreases and as the lung becomes injured. We conclude that our model captures the time-dependent mechanical behavior of the lung due to gradual R/D of lung units.     

Testicular phosphatase activity in rats treated with cyproterone acetate & flutamide

Cyproterone acetate (CPA) and flutamide (F), 2 antiandrogens were tested in the rat, to determine their effect on acid (ACP) and alkaline (ALP) phosphatase activity. 70 fertile male rats were injected with either CPA, F, or testosterone propionate (TP) at either 2.5 or 10 mg. TP was injected either alone or in combination with the others. Histological examinations of the testes were performed. Spermatogenesis was arrested and Leydig cells atrophied in animals treated with CPA or F. Histochemical examination revealed that CPA enhanced ALP and ACP in the testes while F decreased ALP and ACP. TP treatment in combination with either antiandrogens was unable to overcome their effect. The changes in the 2 phosphatases depending on which antiandrogen was injected suggests different modes of action.     

Differential Effects of AGS3 Expression on D2L Dopamine Receptor-Mediated Adenylyl Cyclase Signaling

Activator of G protein signaling 3 (AGS3) binds Gα_i subunits in the GDP-bound state, implicating AGS3 as an important regulator of Gα_i-linked receptor (e.g., D2 dopamine and μ-opioid) signaling. We examined the ability of AGS3 to modulate recombinant adenylyl cyclase (AC) type 1 and 2 signaling in HEK293 cells following both acute and persistent activation of the D_2L dopamine receptor (D_2LDR). AGS3 expression modestly enhanced the potency of acute quinpirole-induced D_2LDR modulation of AC1 or AC2 activity. AGS3 also promoted desensitization of D_2LDR-mediated inhibition of AC1, whereas desensitization of D_2LDR-mediated AC2 activation was significantly attenuated. Additionally, AGS3 reduced D_2LDR-mediated sensitization of AC1 and AC2. These data suggest that AGS3 is involved in altering G protein signaling in a complex fashion that is effector-specific and dependent on the duration of receptor activation.     

Changes in vegetation patterns on the margins of a constructed wetland after 10 years

Summary A constructed urban wetland in Adelaide was surveyed 18 months and 10 years after construction to see how shoreline vegetation, soil electrical conductivity (EC), texture and pH changed over time and to provide data for future site management. Multivariate analysis detected four plant associations at 18 months: salt‐tolerant taxa on conductive clays; a weed‐dominated community on lower EC soil; and two smaller waterlogged, low EC clusters dominated by Common Reed (Phragmites australis) and Sea Club‐Rush (Bolboschoenus caldwellii), respectively. At 10 years, site cover and heterogeneity was higher, with the margins dominated by Phragmites and salt‐tolerant species. EC was much lower and more uniform, and the soils were heavier and more alkaline. Managed storm water flushing apparently lowered soil EC, but possibly also disturbed the shoreline. However, weeds were still common, and the potential for domination by Phragmites at the expense of other native shoreline species means that ongoing monitoring and hydrological and vegetation management are essential to maintain site habitat diversity.     

Cognitive Dysfunction Precedes the Onset of Motor Symptoms in the MitoPark Mouse Model of Parkinson’s Disease

Parkinson’s disease (PD) is a neurodegenerative disorder primarily characterized by progressive loss of dopamine neurons, leading to loss of motor coordination. However, PD is associated with a high rate of non-motor neuropsychiatric comorbities that often develop before the onset of movement symptoms. The MitoPark transgenic mouse model is the first to recapitulate the cardinal clinical features, namely progressive neurodegeneration and death of neurons, loss of motor function and therapeutic response to L-DOPA. To investigate whether MitoPark mice exhibit early onset of cognitive impairment, a non-motor neuropsychiatric comorbidity, we measured performance on a spatial learning and memory task before (∼8 weeks) or after (∼20 weeks) the onset of locomotor decline in MitoPark mice or in littermate controls. Consistent with previous studies, we established that a progressive loss of spontaneous locomotor activity began at 12 weeks of age, which was followed by progressive loss of body weight beginning at 16–20 weeks. Spatial learning and memory was measured using the Barnes Maze. By 20 weeks of age, MitoPark mice displayed a substantial reduction in overall locomotor activity that impaired their ability to perform the task. However, in the 8-week-old mice, locomotor activity was no different between genotypes, yet MitoPark mice took longer, traveled further and committed more errors than same age control mice, while learning to successfully navigate the maze. The modest between-day learning deficit of MitoPark mice was characterized by impaired within-day learning during the first two days of testing. No difference was observed between genotypes during probe trials conducted one or twelve days after the final acquisition test. Additionally, 8-week-old MitoPark mice exhibited impaired novel object recognition when compared to control mice. Together, these data establish that mild cognitive impairment precedes the loss of motor function in a novel rodent model of PD, which may provide unique opportunities for therapeutic development.